Detalhe da pesquisa
1.
Genetically engineered myeloid cells rebalance the core immune suppression program in metastasis.
Cell
; 184(8): 2033-2052.e21, 2021 04 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-33765443
2.
Clinical utilization of blinatumomab and inotuzumab immunotherapy in children with relapsed or refractory B-acute lymphoblastic leukemia.
Pediatr Blood Cancer
; 68(1): e28718, 2021 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-33098744
3.
Reduced Toxicity Conditioning for Nonmalignant Hematopoietic Cell Transplants.
Biol Blood Marrow Transplant
; 26(9): 1646-1654, 2020 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-32534101
4.
Immune determinants of CAR-T cell expansion in solid tumor patients receiving GD2 CAR-T cell therapy.
Cancer Cell
; 42(1): 35-51.e8, 2024 01 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-38134936
5.
Matched Targeted Therapy for Pediatric Patients with Relapsed, Refractory, or High-Risk Leukemias: A Report from the LEAP Consortium.
Cancer Discov
; 11(6): 1424-1439, 2021 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-33563661